申请人:Takeda Pharmaceutical Company Limited
                            
                            
                                公开号:EP2530078A1
                            
                            
                                公开(公告)日:2012-12-05
                            
                            
Provided is a compound having an agonist action on GPR52, which is useful as a prophylactic or therapeutic drug for mental diseases such as schizophrenia and the like, and the like.
A compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof.
                            提供了一种对GPR52具有激动剂作用的化合物,该化合物可作为预防或治疗精神疾病如精神分裂症等的药物。一种由以下通式(I)表示的化合物:其中各个符号的定义如说明书中所述,或其盐形式。